首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1800190

全球蛋白質體學市場：2025-2030 年預測

Global Proteomics Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月01日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

蛋白質體學市場預計將從 2025 年的 367.2 億美元成長到 2030 年的 575.82 億美元，複合年成長率為 9.42%。

由於研究蛋白質及其在生物過程中的作用日益重要，蛋白質體學市場正在經歷顯著成長。蛋白質體學是對生物體蛋白質資料集的全面研究，涵蓋蛋白質的結構、功能以及它們在不同細胞和時間點的變化。該領域為理解蛋白質相互作用、定位及其在生物過程中的參與提供了重要見解，對醫學和生物學研究的進步至關重要。技術進步和個人化醫療需求的不斷成長推動著蛋白質體學市場的發展，但高成本和專業技術人員短缺等挑戰可能會阻礙其成長。儘管有這些挑戰，但預計該市場仍將擴張，尤其是在醫療基礎設施發達、研究資金充足的地區。

關鍵促進因素

技術進步

質譜 (MS) 技術（包括液相層析/質譜 (LC/MS)、氣相層析/質譜 (GC/MS)、傅立葉變換質譜 (FT-MS) 以及雙質譜分析儀（例如基質輔助雷射解吸電離飛行時間/飛行時間(MALDI-TOF/TOF)）的進步是蛋白質體學市場的關鍵驅動力。

個人化醫療需求日益成長

個人化醫療（根據患者個別情況客製化治療）日益受到關注，這推動了蛋白質體學的需求。蛋白質體學能夠深入了解蛋白質的表達和相互作用，從而開發出標靶治療，尤其是針對癌症等疾病。隨著醫療體系優先考慮精準醫療，旨在識別生物標記和治療標靶的蛋白質體學研究資金的增加進一步推動了這一需求，從而推動了市場擴張。

The global proteomics market is experiencing significant growth, driven by the increasing importance of studying proteins and their roles in biological processes. Proteomics, the comprehensive study of an organism's protein dataset, encompasses their structure, functions, and interactions, which vary across cells and over time. This field provides critical insights into protein interactions, localization, and involvement in biological processes, making it essential for advancing medical and biological research. The market is propelled by technological advancements and rising demand for personalized medicine, though challenges such as high costs and a shortage of skilled professionals may hinder growth. Despite these obstacles, the market is poised for expansion, particularly in regions with advanced healthcare infrastructure and strong research funding.

Key Growth Drivers

Technological Advancements

Advancements in technologies such as mass spectrometry (MS), including dual mass analyzers like LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF, are major drivers of the proteomics market. These innovations enable detailed analysis of protein structures, allowing thousands of proteins to be resolved in a single gel. Improvements in protein fractionation techniques and bioinformatics further enhance the ability to process complex proteomic data, driving adoption in research and clinical applications. Increased investments in research and development are also accelerating the development of cutting-edge proteomic tools, supporting market growth.

Rising Demand for Personalized Medicine

The growing focus on personalized medicine, which tailors treatments to individual patient profiles, is boosting demand for proteomics. By providing insights into protein expression and interactions, proteomics enables the development of targeted therapies, particularly for diseases like cancer. This demand is further supported by increased funding for proteomic research, which aims to identify biomarkers and therapeutic targets, driving market expansion as healthcare systems prioritize precision medicine.

Market Segmentation

By Geography

The proteomics market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. North America is expected to hold a significant market share, driven by its rapid adoption of advanced technologies and robust healthcare infrastructure. The region's focus on personalized medicine and substantial investments in research further support market growth. Asia-Pacific is projected to be the fastest-growing region, fueled by rising government funding for proteomics research and increasing interest in precision medicine in countries like China and India, where healthcare systems are expanding rapidly.

Competitive Landscape

Key players, including Proteomics International, Biognosys AG, and Creative Proteomics (a division of Creative Dynamics Inc.), are driving innovation in the proteomics market. These companies focus on developing advanced proteomic technologies and services, enhancing data analysis capabilities, and supporting applications in personalized medicine and biological research, strengthening their market positions.

The global proteomics market is set for robust growth, propelled by advancements in technologies like mass spectrometry and the rising demand for personalized medicine. North America leads due to its advanced infrastructure and research investments, while Asia-Pacific's rapid growth reflects increased funding and healthcare advancements. Despite challenges like high costs and a lack of skilled professionals, the market's trajectory remains positive, driven by the critical role of proteomics in understanding biological processes and developing targeted therapies, supported by ongoing innovation from leading industry players.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology

Microarrays
Spectroscopy
X-Ray Crystallography
Chromatography
Others

By Component

Reagents & Kits
Consumables
Others

By Reagents

Microarrays Reagents
Spectroscopy Reagents
X-Ray Crystallography Reagents
Chromatography Reagents
Other Reagents

By Application

Discovery of Protein Biomarkers
Study of Tumor Metastasis
Neurotrauma and Neurology
Renal Disease Diagnosis
Fetal and Maternal Medicine
Others

By Geography

NorthAmerica
United States
Canada
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Israel
UAE
Saudi Arabia
Others
Asia Pacific
China
India
Australia
South Korea
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY

5.1. Introduction
5.2. Microarrays
5.3. Spectroscopy
5.4. X-Ray Crystallography
5.5. Chromatography
5.6. Others

6. GLOBAL PROTEOMICS MARKET BY COMPONENT

6.1. Introduction
6.2. Reagents & Kits
6.3. Consumables
6.4. Others

7. GLOBAL PROTEOMICS MARKET BY REAGENTS

7.1. Introduction
7.2. Microarrays Reagents
7.3. Spectroscopy Reagents
7.4. X-Ray Crystallography Reagents
7.5. Chromatography Reagents
7.6. Other Reagents

8. GLOBAL PROTEOMICS MARKET BY APPLICATION

8.1. Introduction
8.2. Discovery of Protein Biomarkers
8.3. Study of Tumor Metastasis
8.4. Neurotrauma and Neurology
8.5. Renal Disease Diagnosis
8.6. Fetal and Maternal Medicine
8.7. Others

9. GLOBAL PROTEOMICS MARKET BY GEOGRAPHY

9.1. Introduction
9.2. North America
- 9.2.1. United States
- 9.2.2. Canada
- 9.2.3. Mexico
9.3. South America
- 9.3.1. Brazil
- 9.3.2. Argentina
- 9.3.3. Others
9.4. Europe
- 9.4.1. Germany
- 9.4.2. France
- 9.4.3. United Kingdom
- 9.4.4. Others
9.5. Middle East & Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. Others
9.6. Asia Pacific
- 9.6.1. China
- 9.6.2. Japan
- 9.6.3. South Korea
- 9.6.4. India
- 9.6.5. Others